These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28391088)

  • 1. BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism.
    Isa Kara M; Ertaş ET; Ozen E; Atıcı M; Aksoy S; Erdogan MS; Kelebek S
    Arch Oral Biol; 2017 Aug; 80():69-74. PubMed ID: 28391088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible paroxetine-induced bruxism.
    Romanelli F; Adler DA; Bungay KM
    Ann Pharmacother; 1996 Nov; 30(11):1246-8. PubMed ID: 8913405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.
    Sabuncuoglu O; Ekinci O; Berkem M
    Spec Care Dentist; 2009; 29(5):215-7. PubMed ID: 19740153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in The Netherlands: a multivariate analysis.
    Pathiyal A; Hylan TR; Jones JK; Davtian D; Sverdlov L; Keyser M
    Clin Ther; 1997; 19(4):798-810. PubMed ID: 9377622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine-Induced Sleep Bruxism Rapidly Treated With Once-Nightly Dosing of Buspirone in a 6-Year-Old Girl.
    Akbaş B; Bilgiç A
    Clin Neuropharmacol; 2018; 41(5):197-198. PubMed ID: 29979192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
    J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful monitoring of fluoxetine-induced nocturnal bruxism: a case report.
    Iskandar JW; Wood B; Ali R; Wood RL
    J Clin Psychiatry; 2012 Mar; 73(3):366. PubMed ID: 22490260
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.
    Yunusa I; Gagne JJ; Yoshida K; Bykov K
    JAMA Netw Open; 2022 Feb; 5(2):e220194. PubMed ID: 35201310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
    Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
    Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.